Literature DB >> 28450267

Retinal changes in the Tg-SwDI mouse model of Alzheimer's disease.

Fred G Oliveira-Souza1, Marci L DeRamus1, Thomas van Groen2, Alexis E Lambert3, Mark S Bolding4, Christianne E Strang5.   

Abstract

Alzheimer's disease (AD), a debilitating neurodegenerative illness, is characterized by neuronal cell loss, mental deficits, and abnormalities in several neurotransmitter and protein systems. AD is also associated with visual disturbances, but their causes remain unidentified. We hypothesize that the visual disturbances stem from retinal changes, particularly changes in the retinal cholinergic system, and that the etiology in the retina parallels the etiology in the rest of the brain. To test our hypothesis, quantitative polymerase chain reaction (qPCR) and immunohistochemistry (IHC) were employed to assess changes in acetylcholine receptor (AChR) gene expression, number of retinal cells, and astrocytic gliosis in the Transgenic Swedish, Dutch and Iowa (Tg-SwDI) mouse model as compared to age-matched wild-type (WT). We observed that Tg-SwDI mice showed an initial upregulation of AChR gene expression early on (young adults and middle-aged adults), but a downregulation later on (old adults). Furthermore, transgenic animals displayed significant cell loss in the photoreceptor layer and inner retina of the young adult animals, as well as specific cholinergic cell loss, and increased astrocytic gliosis in the middle-aged adult and old adult groups. Our results suggest that the changes observed in AD cerebrum are also present in the retina and may be, at least in part, responsible for the visual deficits associated with the disease.
Copyright © 2017 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; amyloid precursor protein mutation; histology; qPCR; retinal cholinergic system; vision

Mesh:

Substances:

Year:  2017        PMID: 28450267      PMCID: PMC5495115          DOI: 10.1016/j.neuroscience.2017.04.021

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  82 in total

1.  Vision and cognition in Alzheimer's disease.

Authors:  M Rizzo; S W Anderson; J Dawson; M Nawrot
Journal:  Neuropsychologia       Date:  2000       Impact factor: 3.139

2.  Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease.

Authors:  Lee E Goldstein; Julien A Muffat; Robert A Cherny; Robert D Moir; Maria H Ericsson; Xudong Huang; Christine Mavros; Jennifer A Coccia; Kyle Y Faget; Karlotta A Fitch; Colin L Masters; Rudolph E Tanzi; Leo T Chylack; Ashley I Bush
Journal:  Lancet       Date:  2003-04-12       Impact factor: 79.321

3.  Ocular changes in TgF344-AD rat model of Alzheimer's disease.

Authors:  Yuchun Tsai; Bin Lu; Alexander V Ljubimov; Sergey Girman; Fred N Ross-Cisneros; Alfredo A Sadun; Clive N Svendsen; Robert M Cohen; Shaomei Wang
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-29       Impact factor: 4.799

Review 4.  Alzheimer's disease in the human eye. Clinical tests that identify ocular and visual information processing deficit as biomarkers.

Authors:  Lily Y L Chang; Jennifer Lowe; Alvaro Ardiles; Julie Lim; Angus C Grey; Ken Robertson; Helen Danesh-Meyer; Adrian G Palacios; Monica L Acosta
Journal:  Alzheimers Dement       Date:  2013-09-05       Impact factor: 21.566

5.  Retinal waves in mice lacking the beta2 subunit of the nicotinic acetylcholine receptor.

Authors:  Chao Sun; David K Warland; Jose M Ballesteros; Deborah van der List; Leo M Chalupa
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-29       Impact factor: 11.205

6.  Reconstitution of gamma-secretase activity.

Authors:  Dieter Edbauer; Edith Winkler; Joerg T Regula; Brigitte Pesold; Harald Steiner; Christian Haass
Journal:  Nat Cell Biol       Date:  2003-05       Impact factor: 28.824

7.  Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease.

Authors:  Anat Kesler; Veronika Vakhapova; Amos D Korczyn; Elvira Naftaliev; Meira Neudorfer
Journal:  Clin Neurol Neurosurg       Date:  2011-03-31       Impact factor: 1.876

Review 8.  [Retinal vascular signs: a window to the heart?].

Authors:  Gerald Liew; Jie Jin Wang
Journal:  Rev Esp Cardiol       Date:  2011-05-06       Impact factor: 4.753

9.  Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging.

Authors:  H V Danesh-Meyer; H Birch; J Y-F Ku; S Carroll; G Gamble
Journal:  Neurology       Date:  2006-11-28       Impact factor: 9.910

10.  Alpha7-nicotinic acetylcholine receptors mediate an Abeta(1-42)-induced increase in the level of acetylcholinesterase in primary cortical neurones.

Authors:  L R Fodero; S S Mok; D Losic; L L Martin; M I Aguilar; C J Barrow; B G Livett; D H Small
Journal:  J Neurochem       Date:  2004-03       Impact factor: 5.372

View more
  3 in total

Review 1.  Visual Features in Alzheimer's Disease: From Basic Mechanisms to Clinical Overview.

Authors:  María Alejandra Cerquera-Jaramillo; Mauricio O Nava-Mesa; Rodrigo E González-Reyes; Carlos Tellez-Conti; Alejandra de-la-Torre
Journal:  Neural Plast       Date:  2018-10-14       Impact factor: 3.599

2.  Immunotoxin-Induced Ablation of the Intrinsically Photosensitive Retinal Ganglion Cells in Rhesus Monkeys.

Authors:  Lisa A Ostrin; Christianne E Strang; Kevin Chang; Ashutosh Jnawali; Li-Fang Hung; Baskar Arumugam; Laura J Frishman; Earl L Smith; Paul D Gamlin
Journal:  Front Neurol       Date:  2018-11-27       Impact factor: 4.003

3.  Color and contrast vision in mouse models of aging and Alzheimer's disease using a novel visual-stimuli four-arm maze.

Authors:  Jean-Philippe Vit; Dieu-Trang Fuchs; Ariel Angel; Aharon Levy; Itschak Lamensdorf; Keith L Black; Yosef Koronyo; Maya Koronyo-Hamaoui
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.